Crossmark

Impact of national drug price negotiation policy on the accessibility and utilization of PCSK9 inhibitors in China: an interrupted time series analysis

Crossref DOI link: https://doi.org/10.1186/s12939-024-02208-1

Published Online: 2024-06-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Lingli

Wang, Xiaoye

Yao, Hongting

Ding, Baolong

Gao, Xingyuan

Li, Xin
License Information

Text and Data Mining valid from 2024-06-05

Version of Record valid from 2024-06-05
More Information

Article History

Received: 16 April 2024

Accepted: 30 May 2024

First Online: 5 June 2024

Declarations

:

: Not applicable, as this study does not report on or involve the use of data from animals or human subjects.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below